Literature DB >> 2968499

Unusual branch point selection in processing of human growth hormone pre-mRNA.

K Hartmuth1, A Barta.   

Abstract

Intron A of the human growth hormone gene does not contain an A residue within 56 nucleotides preceding the 3' splice site. The analysis of the excised intron lariat revealed a C residue 28 nucleotides upstream from the 3' splice site as the major branch acceptor nucleotide. Two additional minor branched nucleotides were identified as U residues at positions -22 and -36. An adenosine substitution at position -22 results in lariat formation solely to this nucleotide. Therefore, C and U residues can function efficiently as natural branch acceptors, but an A residue is preferred if available in the proper region. In addition, the data strongly reinforce the importance of the distance constraint for lariat formation. To explain selection of the branch acceptor nucleotide, potential base-pairing interactions of branch point sequences with the U2 RNA are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2968499      PMCID: PMC363380          DOI: 10.1128/mcb.8.5.2011-2020.1988

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  58 in total

1.  Pre-mRNA splicing in vitro requires intact U4/U6 small nuclear ribonucleoprotein.

Authors:  D L Black; J A Steitz
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

2.  U1, U2, and U4/U6 small nuclear ribonucleoproteins are required for in vitro splicing but not polyadenylation.

Authors:  S M Berget; B L Robberson
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

3.  A compensatory base change in U1 snRNA suppresses a 5' splice site mutation.

Authors:  Y Zhuang; A M Weiner
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

4.  Sequence requirements for splicing of higher eukaryotic nuclear pre-mRNA.

Authors:  M Aebi; H Hornig; R A Padgett; J Reiser; C Weissmann
Journal:  Cell       Date:  1986-11-21       Impact factor: 41.582

5.  In vitro processing of a plant pre-mRNA in a HeLa cell nuclear extract.

Authors:  K Hartmuth; A Barta
Journal:  Nucleic Acids Res       Date:  1986-10-10       Impact factor: 16.971

6.  Self-splicing of group II introns in vitro: mapping of the branch point and mutational inhibition of lariat formation.

Authors:  C Schmelzer; R J Schweyen
Journal:  Cell       Date:  1986-08-15       Impact factor: 41.582

7.  Binding of Escherichia coli ribosomal protein S8 to 16 S rRNA. A model for the interaction and the tertiary structure of the RNA binding site.

Authors:  M Mougel; F Eyermann; E Westhof; P Romby; A Expert-Bezançon; J P Ebel; B Ehresmann; C Ehresmann
Journal:  J Mol Biol       Date:  1987-11-05       Impact factor: 5.469

8.  Small nuclear RNAs from Saccharomyces cerevisiae: unexpected diversity in abundance, size, and molecular complexity.

Authors:  N Riedel; J A Wise; H Swerdlow; A Mak; C Guthrie
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

9.  U2 RNA from yeast is unexpectedly large and contains homology to vertebrate U4, U5, and U6 small nuclear RNAs.

Authors:  M Ares
Journal:  Cell       Date:  1986-10-10       Impact factor: 41.582

10.  Mutations in conserved intron sequences affect multiple steps in the yeast splicing pathway, particularly assembly of the spliceosome.

Authors:  U Vijayraghavan; R Parker; J Tamm; Y Iimura; J Rossi; J Abelson; C Guthrie
Journal:  EMBO J       Date:  1986-07       Impact factor: 11.598

View more
  36 in total

1.  A splice site mutant of maize activates cryptic splice sites, elicits intron inclusion and exon exclusion, and permits branch point elucidation.

Authors:  S Lal; J H Choi; J R Shaw; L C Hannah
Journal:  Plant Physiol       Date:  1999-10       Impact factor: 8.340

2.  Mutational analysis of a plant branchpoint and polypyrimidine tract required for constitutive splicing of a mini-exon.

Authors:  Craig G Simpson; Graham Thow; Gillian P Clark; S Nikki Jennings; Jenny A Watters; John W S Brown
Journal:  RNA       Date:  2002-01       Impact factor: 4.942

3.  Crystal structure of a model branchpoint-U2 snRNA duplex containing bulged adenosines.

Authors:  J A Berglund; M Rosbash; S C Schultz
Journal:  RNA       Date:  2001-05       Impact factor: 4.942

4.  Multiple alignment using simulated annealing: branch point definition in human mRNA splicing.

Authors:  A V Lukashin; J Engelbrecht; S Brunak
Journal:  Nucleic Acids Res       Date:  1992-05-25       Impact factor: 16.971

5.  Limited functional equivalence of phylogenetic variation in small nuclear RNA: yeast U2 RNA with altered branchpoint complementarity inhibits splicing and produces a dominant lethal phenotype.

Authors:  L Miraglia; S Seiwert; A H Igel; M Ares
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

6.  Exon as well as intron sequences are cis-regulating elements for the mutually exclusive alternative splicing of the beta tropomyosin gene.

Authors:  D Libri; M Goux-Pelletan; E Brody; M Y Fiszman
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

7.  The 2-kilobase intron of the herpes simplex virus type 1 latency-associated transcript has a half-life of approximately 24 hours in SY5Y and COS-1 cells.

Authors:  Darby L Thomas; Martin Lock; Janice M Zabolotny; Bangalore R Mohan; Nigel W Fraser
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

8.  Model for tissue specific Calcitonin/CGRP-I RNA processing from in vitro experiments.

Authors:  R A Bovenberg; G J Adema; H S Jansz; P D Baas
Journal:  Nucleic Acids Res       Date:  1988-08-25       Impact factor: 16.971

9.  Unusual branch point selection involved in splicing of the alternatively processed Calcitonin/CGRP-I pre-mRNA.

Authors:  G J Adema; R A Bovenberg; H S Jansz; P D Baas
Journal:  Nucleic Acids Res       Date:  1988-10-25       Impact factor: 16.971

10.  UACUAAC is the preferred branch site for mammalian mRNA splicing.

Authors:  Y A Zhuang; A M Goldstein; A M Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.